Purchase Order HHSN302201600068P

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation on May 5, 2015, with a ceiling value of $3,689.35 under firm fixed-price terms. Performance is located in North Bethesda, Maryland, with a completion date of June 5, 2015. The specific goods or services procured are not detailed in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation for blood products on August 12, 2016, with a ceiling value of $16,224.00 and an ultimate completion date of September 11, 2016. Work is performed in Castleton, Indiana. The order carries firm fixed-price pricing with no set-aside designation.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 30, 2017, with a ceiling value of $7,216.30 for genomic analysis equipment and services.</p> <p>Place of performance is North Bethesda, MD. The order is priced on a firm fixed-price basis and has an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Rees Scientific Corporation valued at $4,241.54 on August 9, 2016. Work is performed in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion is scheduled for December 23, 2020. The source does not specify the goods or services procured.</p>

<p>The National Human Genome Research Institute issued a purchase order to Bio-Rad Laboratories, Inc. on May 19, 2016, with a ceiling value of $17,418.48 for firm fixed-price laboratory equipment and supplies. Place of performance is Bethesda, Maryland. The order ultimate completion date is December 22, 2020. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute issued a purchase order to Qiagen, LLC on August 17, 2016, for $4,285.40 under a firm fixed-price arrangement. Performance is located in Bethesda, Maryland, with an ultimate completion date of December 23, 2020. No set-aside was applied to this order. The source does not specify the particular products or services procured under this purchase order.</p>

The National Human Genome Research Institute issued a $12,028 delivery order to Beckman Coulter, Inc. on December 18, 2018, under a single-award Indefinite Delivery Contract with the Office of Logistics and Acquisition Operations for biomedical laboratory equipment, reagents, software, maintenance, and related services. Place of performance is Bethesda, MD. The order carried an ultimate completion date of September 30, 2019. Pricing was firm fixed price with no set-aside designation.

This $9,173 firm fixed price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to Roche Diagnostics Corporation on August 22, 2016. The award does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, has provided critical care analyzers, reagents, test kits,...